Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
42,379,694
-
Shares change
-
+8,074,013
-
Total reported value, excl. options
-
$973,032,101
-
Value change
-
+$189,224,828
-
Number of buys
-
60
-
Number of sells
-
-28
-
Price
-
$22.96
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2019
104 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q4 2019.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,379,694 shares
of 66,399,673 outstanding shares and own 64% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (5,422,312 shares), NEA Management Company, LLC (4,912,306 shares), JANUS HENDERSON GROUP PLC (4,305,248 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4,289,291 shares), WELLINGTON MANAGEMENT GROUP LLP (3,320,751 shares), BAKER BROS. ADVISORS LP (2,708,200 shares), BlackRock Inc. (2,554,766 shares), MPM ASSET MANAGEMENT LLC (2,393,497 shares), FEDERATED HERMES, INC. (2,158,019 shares), and PRIMECAP MANAGEMENT CO/CA/ (2,093,691 shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.